MedPath

Safe Save Medical Cell Sciences & Technology Co., Ltd.

🇹🇼Taiwan
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.safesavecell.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Phase 3
Conditions
Glioblastoma Multiforme
First Posted Date
2020-02-20
Last Posted Date
2020-03-17
Lead Sponsor
Safe Save Medical Cell Sciences & Technology Co.,Ltd.
Target Recruit Count
118
Registration Number
NCT04277221
Locations
🇨🇳

Chang Gung Memorial Hospital, Chiayi branch, Chiayi City, Taiwan

🇨🇳

Chang Gung Memorial Hospital, Kaohsiung branch, Kaohsiung City, Taiwan

🇨🇳

Chang Gung Memorial Hospital, Keelung branch, Keelung, Taiwan

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.